17β-Estradiol Activates Glucose Uptake via GLUT4 Translocation and PI3K/Akt Signaling Pathway in MCF-7 Cells

Endocrinology

Volumn 154, Issue 6, 2013, Pages 1979-1989

  Garrido, Pablo ^a   Morán, Javier ^a   Alonso, Ana ^a   González, Segundo ^a   González González, Celestino ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 [N (7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO] 2 DEOXY DEXTRO GLUCOSE; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLUCOSE DERIVATIVE; GLUCOSE TRANSPORTER 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL MEMBRANE; CELL METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; NUTRITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

4-CHLORO-7-NITROBENZOFURAZAN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MEMBRANE; DEOXYGLUCOSE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; MCF-7 CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SERINE; SIGNAL TRANSDUCTION;

EID: 84878444751     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1558     Document Type: Article

References (58)

1. Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and longterm absence of estrogens. Cancer Res. 1987;47:4355-4360. (Pubitemid 17128144)
2. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev. 1993;15:17-35. (Pubitemid 23269068)
3. Wessler S, Otto C, Wilck N, Stangl V, Fritzemeier KH. Identification of estrogen receptor ligands leading to activation of non-genomic signaling pathways while exhibiting only weak transcriptional activity. J Steroid Biochem Mol Biol. 2006;98:25-35. (Pubitemid 43113241)
4. Moosmann B, Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA. 1999;96:8867-8872. (Pubitemid 29374674)
5. Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000;14:1649-1660.
6. Li L, Haynes MP, Bender JR. Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA. 2003;100:4807-4812. (Pubitemid 36457810)
7. Kang L, Zhang X, Xie Y, et al. Involvement of estrogen receptor variant ER-α36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol. 2010;24:709-721.
8. Windahl SH, Lagerquist MK, Andersson N, et al. Identification of target cells for the genomic effects of estrogens in bone. Endocrinology. 2007;148:5688-5695. (Pubitemid 350146165)
9. Krishnan V, Wang X, Safe S. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J Biol Chem. 1994;269:15912-15917. (Pubitemid 24202193)
10. Watson CS, Jeng YJ, Hu G, Wozniak A, Bulayeva N, Guptarak J. Estrogen- and xenoestrogen-induced ERK signaling in pituitary tumorcells involves estrogen receptor-α interactions with G protein-αi and caveolin I. Steroids. 2012;77:424-432
11. Pelekanou V, Notas G, Kampa M, et al. ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines. Steroids. 2012;77:928-934.
12. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane. Proc Natl Acad Sci USA. 2004;101:2076-2081. (Pubitemid 38229017)
13. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Auricchio F. Src is an initial target of sex steroid hormone action. Ann N Y Acad Sci. 2002;963:185-190. (Pubitemid 34721710)
14. Acconcia F, Ascenzi P, Fabozzi G, Visca P, Marino M. S-palmitoylation modulates human estrogen receptor-α functions. Biochem Biophys Res Commun. 2004;316:878-883. (Pubitemid 38372163)
15. Zhao FQ, Keating AF. Functional properties and genomics of glucose transporters. Current genomics. 2007;8:113-128. (Pubitemid 46690959)
16. Kang SS, Chun YK, Hur MH, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res. 2002;93:1123-1128. (Pubitemid 35314957)
17. Boado RJ, Black KL, Pardridge WM. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Brain Res Mol Brain Res. 1994;27:51-57. (Pubitemid 24324088)
18. Harmon AW, Patel YM. Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat. 2004;85:103-110. (Pubitemid 38987264)
19. Medina RA, Meneses AM, Vera JC, et al. Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells. Endocrinology. 2003;144:4527-4535. (Pubitemid 37204852)
20. Moreno M, Ordoñez P, Alonso A, Diaz F, Tolivia J, Gonzalez C. Chronic 17β-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging. Age (Dordr). 2010;32:1-13.
21. Nadal A, Rovira JM, Laribi O, et al. Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J. 1998;12:1341-1348. (Pubitemid 28475575)
22. González C, Alonso A, Alvarez N, et al. Role of 17β-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy. J Endocrinol. 2000;166:283-291. (Pubitemid 30650566)
23. González C, Alonso A, Diaz F, Patterson AM. Dose- and time-dependent effects of 17β-oestradiol on insulin sensitivity in insulin-dependent tissues of rat: implications of IRS-1. J Endocrinol. 2003;176:367-379. (Pubitemid 36410420)
24. Kumagai S, Holmäng A, Björntorp P. The effects of oestrogen and progesterone on insulin sensitivity in female rats. Acta Physiol Scand. 1993;149:91-97. (Pubitemid 23271325)
25. Karjalainen A, Paassilta M, Heikkinen J, Bäckström AC, Savolainen M, Kesäniemi YA. Effects of peroral and transdermal oestrogen replacement therapy on glucose and insulin metabolism. Clin Endocrinol (Oxf). 2001;54:165-173. (Pubitemid 32193517)
26. Vazquez A, Liu J, Zhou Y, Oltvai ZN. Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Syst Biol. 2010;4:58.
27. Taguchi Y, Koslowski M, Bodenner DL. Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl Recept. 2004;2:5.
28. Keshamouni VG, Mattingly RR, Reddy KB. Mechanism of 17-β-estradiol- induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta. J Biol Chem. 2002;277:22558-22565. (Pubitemid 34967232)
29. Garofalo C, Sisci D, Surmacz E. Leptin interferes with the effects of the antiestrogen ICI 182,780 in MCF-7 breast cancer cells. Clin Cancer Res. 2004;10:6466-6475. (Pubitemid 39346542)
30. Wang Y, Zhou D, Phung S, Masri S, Smith D, Chen S. SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells. Mol Endocrinol. 2011;25:72-82.
31. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994;269:5241-5248.
32. Roman EA, Reis D, Romanatto T, et al. Central leptin action improves skeletal muscle AKT, AMPK, and PGC1 α activation by hypothalamic PI3K-dependent mechanism. Mol Cell Endocrinol. 2010;314:62-69.
33. Rogers NH, Witczak CA, Hirshman MF, Goodyear LJ, Greenberg AS. Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun. 2009;382:646-650.
34. Wakeling AE, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 1991;51:3867-3873.
35. Rai D, Frolova A, Frasor J, Carpenter AE, Katzenellenbogen BS. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol Endocrinol. 2005;19:1606-1617. (Pubitemid 41002989)
36. Yamada K, Saito M, Matsuoka H, Inagaki N. A real-time method of imaging glucose uptake in single, living mammalian cells. Nat Protoc. 2007;2:753-762. (Pubitemid 47040036)
37. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354. (Pubitemid 9256559)
38. Rordorf-Nikolic T, Van Horn DJ, Chen D, White MF, Backer JM. Regulation of phosphatidylinositol 3′-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem. 1995;270:3662-3666.
39. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature. 2000;407:538-541.
40. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernández-Salguero PM. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor α-dependent mechanism: relevance in cell proliferation. Int J Cancer. 2004;109:167-173. (Pubitemid 38240916)
41. Alonso A, Fernández R, Moreno M, et al. Positive effects of 17β-estradiol on insulin sensitivity in aged ovariectomized female rats. J Gerontol A Biol Sci Med Sci. 2006;61:419-426. (Pubitemid 43794699)
42. Bingley CA, Gitau R, Lovegrove JA. Impact of menstrual cycle phase on insulin sensitivity measures and fasting lipids. Horm Metab Res. 2008;40:901-906.
43. Alonso A, Gonzalez-Pardo H, Garrido P, et al. Acute effects of 17β-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats. Age (Dordr). 2010;32:421-434.
44. Avril N, Menzel M, Dose J, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med. 2001;42:9-16. (Pubitemid 32104770)
45. Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519-530.
46. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
47. Kim KH, Toomre D, Bender JR. Splice isoform estrogen receptors as integral transmembrane proteins. Mol Biol Cell. 2011;22:4415-4423.
48. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF. A variant of estrogen receptor-α, hER-α36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA. 2006;103:9063-9068. (Pubitemid 43902533)
49. Márquez DC, Chen HW, Curran EM, Welshons WV, Pietras RJ. Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer. Mol Cell Endocrinol. 2006;246:91-100. (Pubitemid 43238401)
50. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF. Identification, cloning, and expression of human estrogen receptor-α36, a novel variant of human estrogen receptor-α66. Biochem Biophys Res Commun. 2005;336:1023-1027. (Pubitemid 41383424)
51. Penot G, Le Péron C, Mérot Y, et al. The human estrogen receptor-alpha isoform hERα46 antagonizes the proliferative influence of hERα66 in MCF7 breast cancer cells. Endocrinology. 2005;146:5474-5484. (Pubitemid 41653062)
52. Alonso A, Moreno M, Ordóñez P, et al. Chronic estradiol treatment improves brain homeostasis during aging in female rats. Endocrinology. 2008;149:57-72.
53. Acconcia F, Ascenzi P, Bocedi A, et al. Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Mol Biol Cell. 2005;16:231-237. (Pubitemid 40028339)
54. Duan R, Xie W, Li X, McDougal A, Safe S. Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. Biochem Biophys Res Commun. 2002;294:384-394. (Pubitemid 34694107)
55. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 1994;14:4902-4911. (Pubitemid 24196839)
56. Evinger AJ, 3rd, Levin ER. Requirements for estrogen receptor α membrane localization and function. Steroids. 2005;70:361-363. (Pubitemid 40616033)
57. Adler LP, Crowe JP, al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology. 1993;187:743-750. (Pubitemid 23155705)
58. Patronas NJ, Di Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg. 1985;62:816-822. (Pubitemid 15009404)